| Sialic acid metabolism: a key player in breast cancer metastasis revealed by metabolomics ST Teoh, MP Ogrodzinski, C Ross, KW Hunter, SY Lunt Frontiers in oncology 8, 174, 2018 | 86 | 2018 |
| Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation … BE Zucconi, JD Ballin, BY Brewer, CR Ross, J Huang, EA Toth, ... Journal of Biological Chemistry 285 (50), 39127-39139, 2010 | 77 | 2010 |
| In vivo evidence for serine biosynthesis-defined sensitivity of lung metastasis, but not of primary breast tumors, to mTORC1 inhibition G Rinaldi, E Pranzini, J Van Elsen, D Broekaert, CM Funk, M Planque, ... Molecular cell 81 (2), 386-397. e7, 2021 | 75 | 2021 |
| Tristetraprolin: roles in cancer and senescence CR Ross, SE Brennan-Laun, GM Wilson Ageing research reviews 11 (4), 473-484, 2012 | 74 | 2012 |
| A dimer interface mutation in glyceraldehyde-3-phosphate dehydrogenase regulates its binding to AU-rich RNA MR White, MM Khan, D Deredge, CR Ross, R Quintyn, BE Zucconi, ... Journal of Biological Chemistry 290 (3), 1770-1785, 2015 | 58 | 2015 |
| Integrated analyses of murine breast cancer models reveal critical parallels with human disease JP Rennhack, B To, M Swiatnicki, C Dulak, MP Ogrodzinski, Y Zhang, C Li, ... Nature communications 10 (1), 3261, 2019 | 53 | 2019 |
| Antiproliferative activities of halogenated thieno [3, 2-d] pyrimidines KW Temburnikar, SC Zimmermann, NT Kim, CR Ross, C Gelbmann, ... Bioorganic & medicinal chemistry 22 (7), 2113-2122, 2014 | 43 | 2014 |
| Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway L Xu, H Ning, L Gu, Q Wang, W Lu, H Peng, W Cui, B Ying, CR Ross, ... Oncotarget 6 (39), 41679, 2015 | 42 | 2015 |
| Antiproliferative activities of halogenated pyrrolo [3, 2-d] pyrimidines KW Temburnikar, CR Ross, GM Wilson, J Balzarini, BM Cawrse, ... Bioorganic & medicinal chemistry 23 (15), 4354-4363, 2015 | 22 | 2015 |
| The genomic landscape of metastasis in treatment-naive breast cancer models C Ross, K Szczepanek, M Lee, H Yang, T Qiu, JD Sanford, K Hunter PLoS Genetics 16 (5), e1008743, 2020 | 21 | 2020 |
| Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1 DB Mahat, SE Brennan-Laun, EJ Fialcowitz-White, A Kishor, CR Ross, ... PLoS One 7 (3), e33194, 2012 | 18 | 2012 |
| Contributions of the Histidine Side Chain and the N-terminal α-Amino Group to the Binding Thermodynamics of Oligopeptides to Nucleic Acids as a Function of pH JD Ballin, JP Prevas, CR Ross, EA Toth, GM Wilson, MT Record Jr Biochemistry 49 (9), 2018-2030, 2010 | 16 | 2010 |
| Metastasis-specific gene expression in autochthonous and allograft mouse mammary tumor models: stratification and identification of targetable signatures C Ross, K Szczepanek, M Lee, H Yang, CJ Peer, J Kindrick, ... Molecular Cancer Research 18 (9), 1278-1289, 2020 | 14 | 2020 |
| Mitotic arrest of breast cancer MDA-MB-231 cells by a halogenated thieno [3, 2-d] pyrimidine CR Ross, KW Temburnikar, GM Wilson, KL Seley-Radtke Bioorganic & medicinal chemistry letters 25 (8), 1715-1717, 2015 | 13 | 2015 |
| Sialic acid metabolism: a key player in breast cancer metastasis revealed by metabolomics. Front Oncol. 2018; 8: 174 ST Teoh, MP Ogrodzinski, C Ross, KW Hunter, SY Lunt | 4 | |
| Metastatic signatures—The tell-tale signs of metastasis C Ross, K Hunter Academic Press, 2019 | 3 | 2019 |
| Integrated sequence and gene expression analysis of mouse models of breast cancer reveals critical events with human parallels JP Rennhack, M Swiatnicki, Y Zhang, C Li, E Bylett, C Ross, ... bioRxiv, 375154, 2018 | 2 | 2018 |
| Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer MR Majocha, DE Jackson, NH Ha, R Amin, M Pangrácová, CR Ross, ... Plos Genetics 20 (5), e1011236, 2024 | | 2024 |
| Tristetraprolin induces an antitumorigenic phenotype in triple negative breast cancer via a novel non-canonical mechanism JL Rutherford, MB Stemberger, R Mahmud, CR Ross, EJ White, ... Cancer Research 84 (6_Supplement), 5634-5634, 2024 | | 2024 |
| SMARCD1 is a “Goldilocks” metastasis modifier C Ross, LY Gong, LM Jenkins, N Ha, M Majocha, K Hunter bioRxiv, 2024 | | 2024 |
